Jeffrey Arkles

Jeffrey Arkles

Auto-generated profile, based on publicly available information

Jeffrey Arkles

Department of Cardiology, Penn Medicine-Lancaster General Health, Lancaster, Pennsylvania, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2021 in Circulation
Verified
Journal Article
Closed access
PDF file
TMTimothy M. Markman
Timothy M. Markman
CBChase R. Brown
Chase R. Brown
LYLin Yang
Lin Yang
GGGustavo S. Guandalini
Gustavo S. Guandalini
MHMatthew C. Hyman
Matthew C. Hyman
DFDavid S. Frankel
David S. Frankel
Background: Prescription opioids are a major contributor to the ongoing epidemic of persistent opioid use (POU). The incidence of POU among opioid-naïve patients after cardiac implantable electronic device (CIED) procedures is unknown. Methods: This retrospective cohort study used data from a national administrative claims database from 2004 to 2018 of patients undergoing CIED procedures. Adult patients were included if they were opioid-naïve during the 180-day period before the procedure and did not undergo another procedure with anesthesia in the next 180 days. POU was defined by filling an additional opioid prescription >30 days after the CIED procedure. Results: Of the 143 400 patients who met the inclusion criteria, 15 316 (11%) filled an opioid prescription within 14 days of surgery. Among these patients, POU occurred in 1901 (12.4%) patients 30 to 180 days after surgery. The likelihood of developing POU was increased for patients who had a history of drug abuse (odds ratio, 1.52; P =0.005), preoperative muscle relaxant (odds ratio, 1.52; P <0.001) or benzodiazepine (odds ratio, 1.23; P =0.001) use, or opioid use in the previous 5 years (OR, 1.76; P 135 mg of oral morphine equivalents had a significantly increased risk of POU. Conclusions: POU is common after CIED procedures, and 12% of patients continued to use opioids >30 days after surgery. Higher initially prescribed oral morphine equivalent doses were associated with developing POU.

1 December 2021 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
ILIoan Liuba
Ioan Liuba
DMDaniele Muser
Daniele Muser
CCC. Anwar A. Chahal
C. Anwar A. Chahal
CTCory Tschabrunn
Cory Tschabrunn
PSPasquale Santangeli
Pasquale Santangeli
FMFrancis Marchlinski
Francis Marchlinski
Background: The substrate for ventricular tachycardia (VT) in left ventricular (LV) nonischemic cardiomyopathy may be epicardial. We assessed the prevalence, location, endocardial electrograms, and VT ablation outcomes in LV nonischemic cardiomyopathy with isolated epicardial substrate. Methods: Forty-seven of 531 (9%) patients with LV nonischemic cardiomyopathy and VT demonstrated normal endocardial (>1.5 mV)/abnormal epicardial bipolar low-voltage area (LVA, <1.0 mV and signal abnormality). Abnormal endocardial unipolar LVA (≤8.3 mV) and endocardial bipolar split electrograms and predictors of ablation success were assessed. Results: Epicardial bipolar LVA (27.3 cm 2 [interquartile range, 15.8–50.0]) localized to basal (40), mid (8), and apical (3) LV with basal inferolateral LV most common (28/47, 60%). Of 44 endocardial maps available, 40 (91%) had endocardial unipolar LVA (24.5 cm 2 [interquartile range, 9.4–68.5]) and 29 (67%) had characteristic normal amplitude endocardial split electrograms opposite the epicardial LVA. At mean of 34 months, the VT-free survival was 55% after one and 72% after multiple procedures. Greater endocardial unipolar LVA than epicardial bipolar LVA (hazard ratio, 10.66 [CI, 2.63–43.12], P =0.001) and number of inducible VTs (hazard ratio, 1.96 [CI, 1.27–3.00], P =0.002) were associated with VT recurrence. Conclusions: In patients with LV nonischemic cardiomyopathy and VT, the substrate may be confined to epicardial and commonly basal inferolateral. LV endocardial unipolar LVA and normal amplitude bipolar split electrograms identify epicardial LVA. Ablation targeting epicardial VT and substrate achieves good long-term VT-free survival. Greater endocardial unipolar than epicardial bipolar LVA and more inducible VTs predict VT recurrence.

10 December 2020 in Circulation: Arrhythmia and Electrophysiology
Verified
Journal Article
Closed access
PDF file
LKLing Kuo
Ling Kuo
DFDavid S. Frankel
David S. Frankel
ALAung Lin
Aung Lin
JAJeffrey Arkles
Jeffrey Arkles
MHMatthew Hyman
Matthew Hyman
SNSaman Nazarian
Saman Nazarian
Background: We have previously shown that the presence of dual muscular coronary sinus (CS) to left atrial (LA) connections, coupled with rate-dependent unidirectional block in one limb, is associated with atrial fibrillation (AF) induction. This study sought to examine whether ablation of distal CS to LA connections at a first AF ablation reduces arrhythmia recurrence during follow-up. Methods: In this single-center, randomized, controlled trial, 35 consecutive patients with drug-refractory AF undergoing first-time ablation between August 2018 and August 2019, were randomly assigned to (1) standard ablation (pulmonary vein isolation and nonpulmonary vein trigger ablation) versus (2) standard ablation plus elimination of distal CS to LA connections targeting the earliest LA activation during distal CS pacing with a deca-polar catheter placed with its proximal electrode at the ostium. Change of the local CS atrial electrogram and LA activation sequence to early activation of the LA septum or roof during distal CS pacing were the end point for CS-LA connection elimination. Results: Thirty patients completed 6 months study follow-up (15 patients in each group). Demographic characteristics including age and AF persistence were similar in both groups. After a mean follow-up of 170±22 days, there were 7 atrial arrhythmia recurrences in the standard group and 1 recurrence in the CS-LA connection elimination group (46.7% versus 6.7%, hazard ratio, 0.12, P =0.047). Conclusions: Elimination of distal CS to LA connections reduced atrial arrhythmia recurrences compared with standard pulmonary vein isolation and nonpulmonary vein trigger ablation in patients undergoing a first AF ablation procedure in a small randomized study. This strategy warrants further evaluation in a multicenter randomized trial. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT03646643.

25 August 2022 in Neurophotonics
Verified
Journal Article
Open access
PDF file
ALAlec Lafontant
Alec Lafontant
EGElizabeth Mahanna Gabrielli
Elizabeth Mahanna Gabrielli
KBKarla Bergonzi
Karla Bergonzi
RFRodrigo Menezes Forti
Rodrigo Menezes Forti
Tiffany S. KoTiffany S. Ko
Tiffany S. Ko
Wesley BakerWesley Baker
Wesley Baker
Significance: The critical closing pressure (CrCP) of cerebral circulation, as measured by diffuse correlation spectroscopy (DCS), is a promising biomarker of intracranial hypertension. However, CrCP techniques using DCS have not been assessed in gold standard experiments.Aim: CrCP is typically calculated by examining the variation of cerebral blood flow (CBF) during the cardiac cycle (with normal sinus rhythm). We compare this typical CrCP measurement with a gold standard obtained during the drops in arterial blood pressure (ABP) caused by rapid ventricular pacing (RVP) in patients undergoing invasive electrophysiologic procedures.Approach: Adults receiving electrophysiology procedures with planned ablation were enrolled for DCS CBF monitoring. CrCP was calculated from CBF and ABP data by three methods: (1) linear extrapolation of data during RVP (CrCPRVP; the gold standard); (2) linear extrapolation of data during regular heartbeats (CrCPLinear); and (3) fundamental harmonic Fourier filtering of data during regular heartbeats (CrCPFourier).Results: CBF monitoring was performed prior to and during 55 episodes of RVP in five adults. CrCPRVP and CrCPFourier demonstrated agreement (R = 0.66, slope = 1.05 (95%CI, 0.72 to 1.38). Agreement between CrCPRVP and CrCPLinear was worse; CrCPLinear was 8.2 ± 5.9 mmHg higher than CrCPRVP (mean ± SD; p < 0.001).Conclusions: Our results suggest that DCS-measured CrCP can be accurately acquired during normal sinus rhythm.

28 May 2021 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
MKMirmilad Khoshknab
Mirmilad Khoshknab
LKLing Kuo
Ling Kuo
TZTarek Zghaib
Tarek Zghaib
JAJeffrey Arkles
Jeffrey Arkles
PSPasquale Santangeli
Pasquale Santangeli
SNSaman Nazarian
Saman Nazarian

1 October 2021 in Heart Rhythm
Verified
Journal Article
Closed access
JSJeffrey Smietana
Jeffrey Smietana
DFDavid S. Frankel
David S. Frankel
JSJoseph M. Serletti
Joseph M. Serletti
JAJeffrey Arkles
Jeffrey Arkles
NPNaga Venkata K. Pothineni
Naga Venkata K. Pothineni
RSRobert D. Schaller
Robert D. Schaller